Cargando…
Identification of aberrant circulating miRNAs in Parkinson's disease plasma samples
OBJECTIVE: To detect the aberrant expression of circulating miRNAs and explore the potential early diagnostic biomarkers in patients with Parkinson's disease (PD). METHODS: Plasma samples were collected from 25 treatment‐naïve PD‐diagnosed patients and 25 healthy controls followed by a real‐tim...
Autores principales: | Chen, Lei, Yang, Junxiu, Lü, Jinhui, Cao, Shanshan, Zhao, Qian, Yu, Zuoren |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5893342/ https://www.ncbi.nlm.nih.gov/pubmed/29670823 http://dx.doi.org/10.1002/brb3.941 |
Ejemplares similares
-
Identification of Aberrantly Expressed miRNAs in Gastric Cancer
por: Liu, Dan, et al.
Publicado: (2014) -
Circulating miRNAs as Diagnostic Biomarkers for Parkinson’s Disease
por: Roser, Anna Elisa, et al.
Publicado: (2018) -
Aberrant expression of miRNAs in epilepsy
por: Ghafouri-Fard, Soudeh, et al.
Publicado: (2022) -
Circulating Inflammatory miRNAs Associated with Parkinson’s Disease Pathophysiology
por: Oliveira, Sara R., et al.
Publicado: (2020) -
Identification of miRNAs and their target genes in Larix olgensis and verified of differential expression miRNAs
por: Zhang, Sufang, et al.
Publicado: (2019)